ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Leukocyte Antigen Typing and Antibody Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-28Z16893
Home | Market Reports | Science| Biological Sciences
Global Human Leukocyte Antigen Typing and Antibody Testing Market Research Report 2024
BUY CHAPTERS

Global Human Leukocyte Antigen Typing and Antibody Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-28Z16893
Report
November 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Siemens AG
Roche
Thermo Fisher Scientific
Immucor
CareDx
Natera
Eurofins Scientific
Medix Biochemica
GenDx
CGT GLOBAL
Beckman Coulter

Human Leukocyte Antigen Typing and Antibody Testing Market

The global Human Leukocyte Antigen Typing and Antibody Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Human leukocyte antigen (HLA), also known as transplantation antigen, is related to allogeneic tissue and organ transplantation and graft rejection. HLA tissue matching is one of the important factors affecting the survival rate of organ transplantation, hematopoietic stem cell transplantation and the quality of life of the recipient. HLA genes are highly polymorphic and determine the polymorphism of the expressed HLA antigen molecules. Currently, genotyping detection technology is mainly used for HLA typing. Compared with serological and cytological methods, it has higher sensitivity and accuracy and can detect more types.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Human Leukocyte Antigen Typing and Antibody Testing leading manufacturers including Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, CareDx, Natera, Eurofins Scientific, Medix Biochemica, GENDX, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Human Leukocyte Antigen Typing and Antibody Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Human Leukocyte Antigen Typing and Antibody Testing Market Report

Report Metric Details
Report Name Human Leukocyte Antigen Typing and Antibody Testing Market
Segment by Type
  • Antigen Typing
  • Antibody Testing
Segment by Application
  • Hospital
  • Clinic
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, CareDx, Natera, Eurofins Scientific, Medix Biochemica, GENDX, CGT Global, Beckman Coulter
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Human Leukocyte Antigen Typing and Antibody Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Human Leukocyte Antigen Typing and Antibody Testing Market report?

Ans: The main players in the Human Leukocyte Antigen Typing and Antibody Testing Market are Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, CareDx, Natera, Eurofins Scientific, Medix Biochemica, GENDX, CGT Global, Beckman Coulter

What are the Application segmentation covered in the Human Leukocyte Antigen Typing and Antibody Testing Market report?

Ans: The Applications covered in the Human Leukocyte Antigen Typing and Antibody Testing Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Human Leukocyte Antigen Typing and Antibody Testing Market report?

Ans: The Types covered in the Human Leukocyte Antigen Typing and Antibody Testing Market report are Antigen Typing, Antibody Testing

1 Study Coverage
1.1 Introduction to Human Leukocyte Antigen Typing and Antibody Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Antigen Typing
1.2.3 Antibody Testing
1.3 Market Segmentation by Application
1.3.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Human Leukocyte Antigen Typing and Antibody Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Human Leukocyte Antigen Typing and Antibody Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Antigen Typing Market Size by Players
3.3.2 Antibody Testing Market Size by Players
3.4 Global Human Leukocyte Antigen Typing and Antibody Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Type (2020-2031)
6.4 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Type (2020-2031)
7.4 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Type (2020-2031)
9.4 Central and South America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.1.4 Abbott Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Human Leukocyte Antigen Typing and Antibody Testing Revenue by Product in 2024
11.1.6 Abbott Human Leukocyte Antigen Typing and Antibody Testing Revenue by Application in 2024
11.1.7 Abbott Human Leukocyte Antigen Typing and Antibody Testing Revenue by Geographic Area in 2024
11.1.8 Abbott Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Siemens
11.2.1 Siemens Corporation Information
11.2.2 Siemens Business Overview
11.2.3 Siemens Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.2.4 Siemens Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.2.5 Siemens Human Leukocyte Antigen Typing and Antibody Testing Revenue by Product in 2024
11.2.6 Siemens Human Leukocyte Antigen Typing and Antibody Testing Revenue by Application in 2024
11.2.7 Siemens Human Leukocyte Antigen Typing and Antibody Testing Revenue by Geographic Area in 2024
11.2.8 Siemens Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
11.2.9 Siemens Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview
11.3.3 Roche Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.3.4 Roche Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.3.5 Roche Human Leukocyte Antigen Typing and Antibody Testing Revenue by Product in 2024
11.3.6 Roche Human Leukocyte Antigen Typing and Antibody Testing Revenue by Application in 2024
11.3.7 Roche Human Leukocyte Antigen Typing and Antibody Testing Revenue by Geographic Area in 2024
11.3.8 Roche Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
11.3.9 Roche Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.4.4 Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.4.5 Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Revenue by Product in 2024
11.4.6 Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Revenue by Application in 2024
11.4.7 Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Revenue by Geographic Area in 2024
11.4.8 Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
11.4.9 Thermo Fisher Scientific Recent Developments
11.5 Immucor
11.5.1 Immucor Corporation Information
11.5.2 Immucor Business Overview
11.5.3 Immucor Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.5.4 Immucor Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.5.5 Immucor Human Leukocyte Antigen Typing and Antibody Testing Revenue by Product in 2024
11.5.6 Immucor Human Leukocyte Antigen Typing and Antibody Testing Revenue by Application in 2024
11.5.7 Immucor Human Leukocyte Antigen Typing and Antibody Testing Revenue by Geographic Area in 2024
11.5.8 Immucor Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
11.5.9 Immucor Recent Developments
11.6 CareDx
11.6.1 CareDx Corporation Information
11.6.2 CareDx Business Overview
11.6.3 CareDx Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.6.4 CareDx Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.6.5 CareDx Recent Developments
11.7 Natera
11.7.1 Natera Corporation Information
11.7.2 Natera Business Overview
11.7.3 Natera Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.7.4 Natera Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.7.5 Natera Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Corporation Information
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.8.4 Eurofins Scientific Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.8.5 Eurofins Scientific Recent Developments
11.9 Medix Biochemica
11.9.1 Medix Biochemica Corporation Information
11.9.2 Medix Biochemica Business Overview
11.9.3 Medix Biochemica Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.9.4 Medix Biochemica Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.9.5 Medix Biochemica Recent Developments
11.10 GENDX
11.10.1 GENDX Corporation Information
11.10.2 GENDX Business Overview
11.10.3 GENDX Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.10.4 GENDX Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 CGT Global
11.11.1 CGT Global Corporation Information
11.11.2 CGT Global Business Overview
11.11.3 CGT Global Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.11.4 CGT Global Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.11.5 CGT Global Recent Developments
11.12 Beckman Coulter
11.12.1 Beckman Coulter Corporation Information
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Human Leukocyte Antigen Typing and Antibody Testing Product Features and Attributes
11.12.4 Beckman Coulter Human Leukocyte Antigen Typing and Antibody Testing Revenue and Gross Margin (2020-2025)
11.12.5 Beckman Coulter Recent Developments
12 Human Leukocyte Antigen Typing and Antibody TestingIndustry Chain Analysis
12.1 Human Leukocyte Antigen Typing and Antibody Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Human Leukocyte Antigen Typing and Antibody Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Human Leukocyte Antigen Typing and Antibody Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Abbott
Siemens AG
Roche
Thermo Fisher Scientific
Immucor
CareDx
Natera
Eurofins Scientific
Medix Biochemica
GenDx
CGT GLOBAL
Beckman Coulter
List of Tables
 Table 1. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Human Leukocyte Antigen Typing and Antibody Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen Typing and Antibody Testing as of 2024)
 Table 11. Global Human Leukocyte Antigen Typing and Antibody Testing Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Human Leukocyte Antigen Typing and Antibody Testing Companies Headquarters
 Table 13. Global Human Leukocyte Antigen Typing and Antibody Testing Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Human Leukocyte Antigen Typing and Antibody Testing High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Human Leukocyte Antigen Typing and Antibody Testing Growth Accelerators and Market Barriers
 Table 25. North America Human Leukocyte Antigen Typing and Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Human Leukocyte Antigen Typing and Antibody Testing Growth Accelerators and Market Barriers
 Table 27. Europe Human Leukocyte Antigen Typing and Antibody Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Human Leukocyte Antigen Typing and Antibody Testing Investment Opportunities and Key Challenges
 Table 31. Central and South America Human Leukocyte Antigen Typing and Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Human Leukocyte Antigen Typing and Antibody Testing Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Human Leukocyte Antigen Typing and Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Abbott Corporation Information
 Table 35. Abbott Description and Major Businesses
 Table 36. Abbott Product Features and Attributes
 Table 37. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Abbott Revenue Proportion by Product in 2024
 Table 39. Abbott Revenue Proportion by Application in 2024
 Table 40. Abbott Revenue Proportion by Geographic Area in 2024
 Table 41. Abbott Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
 Table 42. Abbott Recent Developments
 Table 43. Siemens Corporation Information
 Table 44. Siemens Description and Major Businesses
 Table 45. Siemens Product Features and Attributes
 Table 46. Siemens Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Siemens Revenue Proportion by Product in 2024
 Table 48. Siemens Revenue Proportion by Application in 2024
 Table 49. Siemens Revenue Proportion by Geographic Area in 2024
 Table 50. Siemens Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
 Table 51. Siemens Recent Developments
 Table 52. Roche Corporation Information
 Table 53. Roche Description and Major Businesses
 Table 54. Roche Product Features and Attributes
 Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Roche Revenue Proportion by Product in 2024
 Table 57. Roche Revenue Proportion by Application in 2024
 Table 58. Roche Revenue Proportion by Geographic Area in 2024
 Table 59. Roche Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
 Table 60. Roche Recent Developments
 Table 61. Thermo Fisher Scientific Corporation Information
 Table 62. Thermo Fisher Scientific Description and Major Businesses
 Table 63. Thermo Fisher Scientific Product Features and Attributes
 Table 64. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Thermo Fisher Scientific Revenue Proportion by Product in 2024
 Table 66. Thermo Fisher Scientific Revenue Proportion by Application in 2024
 Table 67. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
 Table 68. Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
 Table 69. Thermo Fisher Scientific Recent Developments
 Table 70. Immucor Corporation Information
 Table 71. Immucor Description and Major Businesses
 Table 72. Immucor Product Features and Attributes
 Table 73. Immucor Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Immucor Revenue Proportion by Product in 2024
 Table 75. Immucor Revenue Proportion by Application in 2024
 Table 76. Immucor Revenue Proportion by Geographic Area in 2024
 Table 77. Immucor Human Leukocyte Antigen Typing and Antibody Testing SWOT Analysis
 Table 78. Immucor Recent Developments
 Table 79. CareDx Corporation Information
 Table 80. CareDx Description and Major Businesses
 Table 81. CareDx Product Features and Attributes
 Table 82. CareDx Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. CareDx Recent Developments
 Table 84. Natera Corporation Information
 Table 85. Natera Description and Major Businesses
 Table 86. Natera Product Features and Attributes
 Table 87. Natera Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Natera Recent Developments
 Table 89. Eurofins Scientific Corporation Information
 Table 90. Eurofins Scientific Description and Major Businesses
 Table 91. Eurofins Scientific Product Features and Attributes
 Table 92. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Eurofins Scientific Recent Developments
 Table 94. Medix Biochemica Corporation Information
 Table 95. Medix Biochemica Description and Major Businesses
 Table 96. Medix Biochemica Product Features and Attributes
 Table 97. Medix Biochemica Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Medix Biochemica Recent Developments
 Table 99. GENDX Corporation Information
 Table 100. GENDX Description and Major Businesses
 Table 101. GENDX Product Features and Attributes
 Table 102. GENDX Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. GENDX Recent Developments
 Table 104. CGT Global Corporation Information
 Table 105. CGT Global Description and Major Businesses
 Table 106. CGT Global Product Features and Attributes
 Table 107. CGT Global Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. CGT Global Recent Developments
 Table 109. Beckman Coulter Corporation Information
 Table 110. Beckman Coulter Description and Major Businesses
 Table 111. Beckman Coulter Product Features and Attributes
 Table 112. Beckman Coulter Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Beckman Coulter Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human Leukocyte Antigen Typing and Antibody Testing Product Picture
 Figure 2. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Antigen Typing Product Picture
 Figure 4. Antibody Testing Product Picture
 Figure 5. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Other
 Figure 9. Human Leukocyte Antigen Typing and Antibody Testing Report Years Considered
 Figure 10. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Region (2020-2031)
 Figure 14. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Antigen Typing Revenue Market Share by Player in 2024
 Figure 17. Antibody Testing Revenue Market Share by Player in 2024
 Figure 18. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Type (2020-2031)
 Figure 19. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Application (2020-2031)
 Figure 20. North America Human Leukocyte Antigen Typing and Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. North America Top 5 Players Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) in 2024
 Figure 22. North America Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Type (2020 - 2031)
 Figure 23. North America Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 24. US Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 25. Canada Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 26. Mexico Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 27. Europe Human Leukocyte Antigen Typing and Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Top 5 Players Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) in 2024
 Figure 29. Europe Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Type (2020-2031)
 Figure 30. Europe Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 31. Germany Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 32. France Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 33. U.K. Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 34. Italy Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 35. Russia Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Top 8 Players Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) in 2024
 Figure 38. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Type (2020-2031)
 Figure 39. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 40. Indonesia Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 41. Japan Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 42. South Korea Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 43. Australia Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 44. India Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 45. Indonesia Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 46. Vietnam Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 47. Malaysia Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 48. Philippines Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 49. Singapore Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 50. Central and South America Human Leukocyte Antigen Typing and Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Central and South America Top 5 Players Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) in 2024
 Figure 52. Central and South America Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Central and South America Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Brazil Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 55. Argentina Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 56. Middle East and Africa Human Leukocyte Antigen Typing and Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Top 5 Players Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) in 2024
 Figure 58. South America Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Middle East and Africa Human Leukocyte Antigen Typing and Antibody Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 60. GCC Countries Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 61. Israel Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 62. Egypt Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 63. South Africa Human Leukocyte Antigen Typing and Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 64. Human Leukocyte Antigen Typing and Antibody Testing Industry Chain Mapping
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global HLA Antigen Typing and Antibody Detection Market Research Report 2024
Global HLA Typing Services Market Research Report 2024
Global Human Leukocyte Antigen HLA Testing Market Research Report 2024
Global Human Leukocyte Antigen Testing Market Research Report 2024
Global HLA Testing Market Research Report 2024
Organ Transplant Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CD Antigen Cancer Therapy Market Research Report 2025
Serological Transplant Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PD L1 Biomarker Testing Market Insights Forecast to 2030
Global Allogeneic Human Chondrocyte Market Research Report 2024
Global Organ and Tissue Transplantation and Alternative Market Research Report 2024
Global Leukocyte Surface Antigen CD47 Antibody Market Research Report 2024
Global Blood Type Testing Market Research Report 2024
Global PD L1 and PIK3CA Testing Market Research Report 2024
Human Leukocyte Antigen HLA Typing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HLA Typing Kit Market Research Report 2024
Global Tissue Testing Market Research Report 2024
Global Automated IHC Staining System Market Research Report 2024
Global Gene Transplant Market Research Report 2024
Global Fungal Infection Antigen Test Market Research Report 2024

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions